WNV Core Antibody
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Rad51, N-terminal
Phospho-mu-Opioid Receptor (Ser375) Antibody
Biology Products:...e patients may soon be possible, thanks to a disco...bia neuroscience researchers who have found a new ...y chemicals are lost from brain cells during strok...tims. , The findings were published recently in S...next month,s issue of Nature Reviews Neuroscience....
... can be effectively repaired by tissue engineering... process concludes research led by scientists at t... of tissue engineered cartilage implanted in injur...he July 2006 (Volume 12, Number 7) issue of Tissue...ge tissue can grow and mature when implanted into ...
...e announced Quebec,s first successful combined hea...age 54 years, was transferred from the Institut de...HC. The patient received his new heart and liver d... discharged 10 days later. The complex procedure i...are professionals. The MUHC conducts the most orga...
...ersity College London) have discovered that even w...hed today in Nature, shows that lower-ranked femal... higher up the chain because they have less to los...s and wear themselves out. , The study, funded b... reveals that those higher up the chain and theref...
Other Biology News:UBC researchers find stroke death channel 2MUHC announces a transplant first in Quebec 2Wasps queue for top job 2(Date:5/16/2008)...onsors Program to Recognize Exemplary Work ...IA, May 16 /- CURE magazine announced...y Healer Award for Oncology Nursing,during a recep...Annual,Congress. Ortho Biotech Products, L. P. spo... demonstrate unwavering dedication, compassion and...
(Date:5/16/2008).../- Senesco,Technologies, In...y reported,financial results for the three months ...th period ended March 31, 2008 was $2.0,million, o...8 million, or,$0.05 per share, for the three month... loss was primarily the result of an increase of $...
(Date:5/16/2008)...FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NA...ing interim,results of a Phase II study of intrave...tic to the lung is available on the American Socie...www.asco.org and on the Oncolytics,website at ht...ntitled "A Phase II,Study of Intravenous REOLYSIN ...
(Date:5/16/2008)... /- Arpida Ltd.,(SWX: ARPN)...istration,(FDA) has accepted for review the New Dr...he treatment of complicated Skin and Skin,Structur...ion of the NDA to,the agency in March 2008. FDA ha...prim NDA and has established the Prescription Drug...
Breaking Biology Technology:CURE Magazine Announces Winner of 2008 Extraordinary Healer Award 2Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 7Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 8Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3...are has released a new medical imaging product fo...ance the image reading capabilities of radiologist...ct, marketed as Merge Mammo(TM) version 7.0, will ...images on devices ranging from ultrasound to digit...sition device is used to secure the images. The co...
... in a series of articles on developing start-up co.... The most recent article focused on the tax law i...rs. In this article, the authors address unemploym... unemployment insurance statute has its own test f...ough this test is similar in many respects to the ...
...se more venture capital for clinical trials, ZySt...g at the annual InvestMidwest venture capital for...hich also presented at the 2006 forum, would like ...cipation of Phase I clinical trials that are set t... the Technology Innovation Center at Milwaukee Co...
...ng with U.S. Health and Human Services Secretary...healthcare organizations pledged to support health...interoperability standards in the health informati... , ,The pledge came as part of an effort to suppo...care quality, information reporting, and cost-effe...
Other Biology Technology:Early Stage, Step 8: Misclassifying workers brings risk 2Early Stage, Step 8: Misclassifying workers brings risk 3Early Stage, Step 8: Misclassifying workers brings risk 4Early Stage, Step 8: Misclassifying workers brings risk 5ZyStor seeks to raise $15M for clinical trials 2ZyStor seeks to raise $15M for clinical trials 3Wisconsin firms pledge to support healthcare IT standards 2